{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:28:17Z","timestamp":1774682897763,"version":"3.50.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001517","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T00:54:27Z","timestamp":1380070467000},"page":"e1001517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":425,"title":["Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites"],"prefix":"10.1371","volume":"10","author":[{"given":"Daniel R.","family":"Feikin","sequence":"first","affiliation":[]},{"given":"Eunice W.","family":"Kagucia","sequence":"additional","affiliation":[]},{"given":"Jennifer D.","family":"Loo","sequence":"additional","affiliation":[]},{"given":"Ruth","family":"Link-Gelles","sequence":"additional","affiliation":[]},{"given":"Milo A.","family":"Puhan","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Cherian","sequence":"additional","affiliation":[]},{"given":"Orin S.","family":"Levine","sequence":"additional","affiliation":[]},{"given":"Cynthia G.","family":"Whitney","sequence":"additional","affiliation":[]},{"given":"Katherine L.","family":"O\u2019Brien","sequence":"additional","affiliation":[]},{"given":"Matthew R.","family":"Moore","sequence":"additional","affiliation":[]},{"name":"the Serotype Replacement Study Group","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2012) Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/immunization_monitoring\/burden\/Pneumo_hib_estimates\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/immunization_monitoring\/burden\/Pneumo_hib_estimates\/en\/index.html<\/ext-link>. Accessed 18 February 2013."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"T Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998\u20132007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study","volume":"49","author":"JD Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"RJ Singleton","year":"2007","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"KL O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"SS Huang","year":"2005","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"S Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by <italic>Streptococcus pneumoniae<\/italic> in children younger than 5 years: global estimates","volume":"374","author":"KL O'Brien","year":"2009","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e30787","DOI":"10.1371\/journal.pone.0030787","article-title":"The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya","volume":"7","author":"O Abdullahi","year":"2012","journal-title":"PLoS One"},{"key":"ref10","first-page":"434","article-title":"Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"ref11","unstructured":"Conklin L, Knoll MD, Loo JD, Fleming-Dutra K, Park D, <etal>et al<\/etal>.. (2011) Landscape analysis of pneumococcal conjugate vaccine dosing schedules: A systematic review (Report to the Strategic Advisory Group of Experts on Immunization (SAGE), World Health Organization). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/immunization\/sage\/3_Conklin_L_PCV_Dosing_Landscape_Report_Oct_17_2011_FINAL_nov11.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/immunization\/sage\/3_Conklin_L_PCV_Dosing_Landscape_Report_Oct_17_2011_FINAL_nov11.pdf<\/ext-link>. Accessed 18 February 2013."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"IH Park","year":"2008","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"WP Hausdorff","year":"2001","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"DM Weinberger","year":"2011","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.vaccine.2011.02.016","article-title":"Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges","volume":"29","author":"G Hanquet","year":"2011","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"E Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2307\/2532090","article-title":"Fieller\u2019s Theorem, the Likelihood and the Delta Method","volume":"46","author":"C Cox","year":"1990","journal-title":"Biometrics"},{"key":"ref18","unstructured":"Beaton GH, United Nations. Subcommittee on Nutrition (1992) Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. Nutrition policy discussion paper number 13. Geneva: ACC\/SCN. 120p."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"MJ Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"ref20","unstructured":"Borenstein M, Hedges L., Rothstein H. (2007) Introduction to meta-analysis. pp.2\u2013303. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.meta-analysis.com\/downloads\/Meta%20Analysis%20Fixed%20vs%20Random%20effects.pdf\" xlink:type=\"simple\">http:\/\/www.meta-analysis.com\/downloads\/Meta%20Analysis%20Fixed%20vs%20Random%20effects.pdf<\/ext-link>. Accessed 18 February 2013."},{"key":"ref21","first-page":"S27","article-title":"Invasive pneumococcal disease in the Northern Territory of Australia, 1994\u20131998","volume":"173 Suppl","author":"VL Krause","year":"2000","journal-title":"Med J Aust"},{"key":"ref22","first-page":"E151","article-title":"Invasive pneumococcal disease in Australia 2007 and 2008","volume":"36","author":"C Barry","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1017\/S0950268808001301","article-title":"Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997\u20132006","volume":"137","author":"J Motlova","year":"2009","journal-title":"Epidemiol Infect"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e51460","DOI":"10.1371\/journal.pone.0051460","article-title":"Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark","volume":"8","author":"ZB Harboe","year":"2013","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-011-1251-9","article-title":"Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine","volume":"30","author":"N Grall","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00431-004-1447-4","article-title":"Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children","volume":"163","author":"NP Zissis","year":"2004","journal-title":"Eur J Pediatr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S0950268810001743","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in the Republic of Ireland","volume":"139","author":"I Vickers","year":"2011","journal-title":"Epidemiol Infect"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel","volume":"30","author":"S Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"AM van Deursen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1017\/S0950268807008588","article-title":"Invasive pneumococcal disease in New Zealand 1998\u20132005: capsular serotypes and antimicrobial resistance","volume":"136","author":"HM Heffernan","year":"2008","journal-title":"Epidemiol Infect"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"DF Vestrheim","year":"2008","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Lamb KE, Flasche S, Diggle M, Inverarity D, Greenhalgh D, <etal>et al<\/etal>.. (2013) Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999\u20132010. Vaccine. In press.","DOI":"10.1016\/j.vaccine.2013.05.079"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2009-2150","article-title":"Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use","volume":"126","author":"T Pilishvili","year":"2010","journal-title":"Pediatrics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/651680","article-title":"Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease","volume":"50","author":"R Weatherholtz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/INF.0b013e318124a494","article-title":"Surveillance for invasive pneumococcal disease during 2000\u20132005 in a population of children who received 7-valent pneumococcal conjugate vaccine","volume":"26","author":"S Black","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"CL Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref37","unstructured":"GAVI Alliance (2011) GAVI Alliance Country Eligibility Policy. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.gavialliance.org\/about\/governance\/programme-policies\/country-eligibility\/\" xlink:type=\"simple\">www.gavialliance.org\/about\/governance\/programme-policies\/country-eligibility\/<\/ext-link>. Accessed 31 May 2013."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/INF.0b013e3181c391fb","article-title":"The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation","volume":"29","author":"S Black","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"ref39","first-page":"129","article-title":"Pneumococcal vaccine WHO position paper - 2012","volume":"14","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"E Miller","year":"2011","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"AA Palmu","year":"2012","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/INF.0b013e3182748ada","article-title":"The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska Native children: results of a clinical trial","volume":"32","author":"R Singleton","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"AB Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.vaccine.2009.10.085","article-title":"The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model","volume":"28","author":"D Bogaert","year":"2010","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"KL Sleeman","year":"2006","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/EDE.0b013e3182087634","article-title":"Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations","volume":"22","author":"DM Weinberger","year":"2011","journal-title":"Epidemiology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"CG Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"HE Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/QAD.0b013e32833d46fd","article-title":"Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization","volume":"24","author":"AL Cohen","year":"2010","journal-title":"AIDS"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/341896","article-title":"Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines","volume":"35","author":"DR Feikin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/13.1.56","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979\u20131989","volume":"13","author":"A Fenoll","year":"1991","journal-title":"Rev Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","article-title":"Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades","volume":"50","author":"ZB Harboe","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1086\/593334","article-title":"Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994\u20132007","volume":"198","author":"R Lagos","year":"2008","journal-title":"J Infect Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"WP Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"R Dagan","year":"2009","journal-title":"J Infect Dis"},{"key":"ref56","volume":"379","unstructured":"Hausdorff WP, Van Dyke MK, Van Effelterre T (2012) Serotype replacement after pneumococcal vaccination. Lancet <volume>379<\/volume>: : 1387\u20131388; author reply 1388\u20131389."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"RE Black","year":"2010","journal-title":"Lancet"},{"key":"ref58","first-page":"12","article-title":"Review of serotype replacement in the setting of 7-valent pneumococcal conjugate vaccine (PCV-7) use and implications for the PCV10\/PCV13 era","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"KA Robinson","year":"2001","journal-title":"JAMA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"AM van Deursen","year":"2012","journal-title":"Emerg Infect Dis"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T21:15:23Z","timestamp":1646601323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001517"}},"subtitle":[],"editor":[{"given":"C\u00e9cile","family":"Viboud","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001517","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]}}}